Top in rheumatology: RA guidelines, mavrilimumab for severe COVID-19
1 month ago - By Healio
The American College of Rheumatology released its updated 2021 guidelines, which includes 44 recommendations on rheumatoid arthritis. A review of the recommendations was the top story in rheumatology last week.
In another top story, researchers of an ongoing, global, randomized, double-blind, placebo-controlled transition phase 2/3 trial reported that mavrilimumab showed promise in patients with severe COVID-19. The treatment was tested in 116 patients in the U.S., Brazil, Chile, Peru and South Africa.
Read these and more top stories in rheumatology below:
ACR RA guidelines: 'Maximize'
Read more ...